PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析

◆英語タイトル:PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review
◆商品コード:DATA904C12003
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PricewaterhouseCoopers LLP (UK) – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

PricewaterhouseCoopers LLP (UK) (PwC), a subsidiary of PricewaterhouseCoopers International Ltd, is a provider of consulting services. The company offers a wide portfolio of services including financial statement audit, risk assurance, regulatory compliance and reporting, international financial reporting standards (IFRS) reporting, capital market transactions advisory, financial accounting, actuarial insurance services, and internal audit. PwC also offers advisory services on fund-raising, legal matters, project finance, private equity advisory, public company advisory, privatization advice, strategic acquisitions, and valuation consulting services among others. Through these services, it caters to industries such as automotive, power and utilities, chemicals, oil and gas, mining, technology and communications, media and entertainment, financial services and government sectors. PwC is headquartered in London, the UK.

PricewaterhouseCoopers LLP Key Recent Developments

Nov 14,2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022
Nov 14,2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022
Apr 27,2018: PwC wins five titles at the MCA Awards
Apr 11,2018: UK manufacturers fall behind in digital adoption, says study
Feb 28,2018: PwC expands business transformation consulting offering with new Chief Experience Officer hire

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
PricewaterhouseCoopers LLP (UK) – Key Facts 5
PricewaterhouseCoopers LLP (UK) – Key Employees 6
PricewaterhouseCoopers LLP (UK) – Key Employee Biographies 7
PricewaterhouseCoopers LLP (UK) – Major Products and Services 8
PricewaterhouseCoopers LLP (UK) – History 12
PricewaterhouseCoopers LLP (UK) – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
PricewaterhouseCoopers LLP (UK) – Business Description 16
PricewaterhouseCoopers LLP (UK) – Corporate Strategy 17
PricewaterhouseCoopers LLP (UK) – SWOT Analysis 18
SWOT Analysis – Overview 18
PricewaterhouseCoopers LLP (UK) – Strengths 18
PricewaterhouseCoopers LLP (UK) – Weaknesses 19
PricewaterhouseCoopers LLP (UK) – Opportunities 20
PricewaterhouseCoopers LLP (UK) – Threats 21
PricewaterhouseCoopers LLP (UK) – Key Competitors 22
Section 3 – Company’s Recent Developments 23
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 23
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 24
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 25
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 26
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 27
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 28
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 29
Nov 14, 2018: 14 Nov 2018 IASB delays new insurance contract rules for one year: PwC comments Alex Bertolotti, IFRS17 leader at PwC, comments on the International Accounting Standards Board decision to delay IFRS17 implementation until 2022 30
Apr 27, 2018: PwC wins five titles at the MCA Awards 31
Apr 11, 2018: UK manufacturers fall behind in digital adoption, says study 32
Section 4 – Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
PricewaterhouseCoopers LLP (UK), Key Facts 5
PricewaterhouseCoopers LLP (UK), Key Employees 6
PricewaterhouseCoopers LLP (UK), Key Employee Biographies 7
PricewaterhouseCoopers LLP (UK), Major Products and Services 8
PricewaterhouseCoopers LLP (UK), History 12
PricewaterhouseCoopers LLP (UK), Other Locations 13
PricewaterhouseCoopers LLP (UK), Subsidiaries 14
PricewaterhouseCoopers LLP (UK), Key Competitors 22

★海外企業調査レポート[PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genesis Healthcare, Inc.:戦略・SWOT・企業財務分析
    Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析
    Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Nexen Energy ULC:石油・ガス:M&Aディール及び事業提携情報
    Summary Nexen Energy ULC (Nexen Energy), formerly Nexen Inc., a subsidiary of CNOOC Limited, is an upstream oil and gas company that discovers and develops energy resources. It is involved in the production of conventional oil and gas, oil sands, and shale gas. The company’s activities include explo …
  • CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. …
  • Intellipharmaceutics International Inc (IPCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosa …
  • Fonterra Co-operative Group Ltd:戦略・SWOT・企業財務分析
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • STMicroelectronics N.V. (STM)-エネルギー分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Shanghai Zhenhua Heavy Industry Co Ltd:戦略・SWOT・企業財務分析
    Shanghai Zhenhua Heavy Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Zhenhua Heavy Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Partner Reinsurance Asia Pte. Ltd.
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • RP Management LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary RP Management LLC (RP Management) is a life sciences financing company that offers biopharmaceutical products. The company’s products include thalomid, myozyme, lexiscan, rituxan, atripla, lyrica, prezista, letairis, januvia, onglyza, neupogen, rotateq, cubicin, savella, and others. It also …
  • Lonmin Plc:企業の戦略・SWOT・財務情報
    Lonmin Plc - Strategy, SWOT and Corporate Finance Report Summary Lonmin Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bio-Path Holdings Inc (BPTH):企業の財務・戦略的SWOT分析
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • Federal Electricity & Water Authority:企業の戦略的SWOT分析
    Federal Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Rompetrol Rafinare SA (RRC):企業の財務・戦略的SWOT分析
    Rompetrol Rafinare SA (RRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Virgin Group Ltd.:企業の戦略・SWOT・財務分析
    Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers co …
  • Sonatrach SPA:企業の戦略的SWOT分析
    Sonatrach SPA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆